Literature DB >> 24291210

D-polyglutamine amyloid recruits L-polyglutamine monomers and kills cells.

Karunakar Kar1, Irene Arduini1, Kenneth W Drombosky1, Patrick C A van der Wel2, Ronald Wetzel3.   

Abstract

Polyglutamine (polyQ) amyloid fibrils are observed in disease tissue and have been implicated as toxic agents responsible for neurodegeneration in expanded CAG repeat diseases such as Huntington's disease. Despite intensive efforts, the mechanism of amyloid toxicity remains unknown. As a novel approach to probing polyQ toxicity, we investigate here how some cellular and physical properties of polyQ amyloid vary with the chirality of the glutamine residues in the polyQ. We challenged PC12 cells with small amyloid fibrils composed of either L- or D-polyQ peptides and found that D-fibrils are as cytotoxic as L-fibrils. We also found using fluorescence microscopy that both aggregates effectively seed the aggregation of cell-produced L-polyQ proteins, suggesting a surprising lack of stereochemical restriction in seeded elongation of polyQ amyloid. To investigate this effect further, we studied chemically synthesized D- and L-polyQ in vitro. We found that, as expected, D-polyQ monomers are not recognized by proteins that recognize L-polyQ monomers. However, amyloid fibrils prepared from D-polyQ peptides can efficiently seed the aggregation of L-polyQ monomers in vitro, and vice versa. This result is consistent with our cell results on polyQ recruitment but is inconsistent with previous literature reports on the chiral specificity of amyloid seeding. This chiral cross-seeding can be rationalized by a model for seeded elongation featuring a "rippled β-sheet" interface between seed fibril and docked monomers of opposite chirality. The lack of chiral discrimination in polyQ amyloid cytotoxicity is consistent with several toxicity mechanisms, including recruitment of cellular polyQ proteins.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DLS; EM; FTIR; Fourier transform infrared; HD; Huntington's disease; PBS; chiral cross-seeding; dynamic light scattering; electron microscopy; phosphate-buffered saline; recruitment; rippled β-sheet; toxicity

Mesh:

Substances:

Year:  2013        PMID: 24291210      PMCID: PMC3910295          DOI: 10.1016/j.jmb.2013.11.019

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  68 in total

1.  Kinetic analysis of beta-amyloid fibril elongation.

Authors:  Michelle J Cannon; Angela D Williams; Ronald Wetzel; David G Myszka
Journal:  Anal Biochem       Date:  2004-05-01       Impact factor: 3.365

2.  Structural control of self-assembled nanofibers by artificial beta-sheet peptides composed of D- or L-isomer.

Authors:  Tomoyuki Koga; Miho Matsuoka; Nobuyuki Higashi
Journal:  J Am Chem Soc       Date:  2005-12-21       Impact factor: 15.419

3.  If it's not one thing, it's another.

Authors:  Henry L Paulson
Journal:  Nat Genet       Date:  2006-07       Impact factor: 38.330

4.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

Review 5.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

6.  Transcriptional activation modulated by homopolymeric glutamine and proline stretches.

Authors:  H P Gerber; K Seipel; O Georgiev; M Höfferer; M Hug; S Rusconi; W Schaffner
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

7.  Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

Authors:  Wen Yang; John R Dunlap; Richard B Andrews; Ronald Wetzel
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

Review 8.  An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.

Authors:  G Cisbani; F Cicchetti
Journal:  Cell Death Dis       Date:  2012-08-30       Impact factor: 8.469

9.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

10.  Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease.

Authors:  Kirupa Sathasivam; Amin Lane; Justin Legleiter; Alice Warley; Ben Woodman; Steve Finkbeiner; Paolo Paganetti; Paul J Muchowski; Stuart Wilson; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

View more
  10 in total

1.  Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.

Authors:  Kenneth W Drombosky; Sascha Rode; Ravi Kodali; Tija C Jacob; Michael J Palladino; Ronald Wetzel
Journal:  Neurobiol Dis       Date:  2018-08-30       Impact factor: 5.996

2.  Suppression of Oligomer Formation and Formation of Non-Toxic Fibrils upon Addition of Mirror-Image Aβ42 to the Natural l-Enantiomer.

Authors:  Subrata Dutta; Alejandro R Foley; Christopher J A Warner; Xiaolin Zhang; Marco Rolandi; Benjamin Abrams; Jevgenij A Raskatov
Journal:  Angew Chem Int Ed Engl       Date:  2017-07-19       Impact factor: 15.336

Review 3.  Biomaterials via peptide assembly: Design, characterization, and application in tissue engineering.

Authors:  Vincent P Gray; Connor D Amelung; Israt Jahan Duti; Emma G Laudermilch; Rachel A Letteri; Kyle J Lampe
Journal:  Acta Biomater       Date:  2021-10-25       Impact factor: 8.947

4.  Delayed emergence of subdiffraction-sized mutant huntingtin fibrils following inclusion body formation.

Authors:  Steffen J Sahl; Lana Lau; Willianne I M Vonk; Lucien E Weiss; Judith Frydman; W E Moerner
Journal:  Q Rev Biophys       Date:  2015-09-09       Impact factor: 5.318

5.  Rippled β-Sheet Formation by an Amyloid-β Fragment Indicates Expanded Scope of Sequence Space for Enantiomeric β-Sheet Peptide Coassembly.

Authors:  Jennifer M Urban; Janson Ho; Gavin Piester; Riqiang Fu; Bradley L Nilsson
Journal:  Molecules       Date:  2019-05-23       Impact factor: 4.411

6.  Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease.

Authors:  Irina Matlahov; Patrick Ca van der Wel
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-15

7.  Chiral Selectivity of Secondary Nucleation in Amyloid Fibril Propagation.

Authors:  Mattias Törnquist; Sara Linse
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-05       Impact factor: 15.336

8.  Mapping the sequence specificity of heterotypic amyloid interactions enables the identification of aggregation modifiers.

Authors:  Nikolaos Louros; Meine Ramakers; Emiel Michiels; Katerina Konstantoulea; Chiara Morelli; Teresa Garcia; Nele Moonen; Sam D'Haeyer; Vera Goossens; Dietmar Rudolf Thal; Dominique Audenaert; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Commun       Date:  2022-03-15       Impact factor: 17.694

9.  Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance.

Authors:  Cody L Hoop; Hsiang-Kai Lin; Karunakar Kar; Zhipeng Hou; Michelle A Poirier; Ronald Wetzel; Patrick C A van der Wel
Journal:  Biochemistry       Date:  2014-10-16       Impact factor: 3.162

10.  Intrinsic property of phenylalanine to trigger protein aggregation and hemolysis has a direct relevance to phenylketonuria.

Authors:  Bibin G Anand; Kriti Dubey; Dolat S Shekhawat; Karunakar Kar
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.